Evidence map›Paper›PMID 27989508›Full record

ArticleCell systems2017

A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease.

Nicholas T Seyfried, Eric B Dammer, Vivek Swarup, Divya Nandakumar, Duc M Duong, Luming Yin, Qiudong Deng, Tram Nguyen, Chadwick M Hales, Thomas Wingo and 7 more

Abstract read
In one paragraph

Article in Cell systems, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 326 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
326citing papers in PubMed, 3 pooled it
18.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

326 citing papers in PubMed, 3 syntheses or guidelines pooled it, 523 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Target discovery and drug design in the era of artificial intelligence.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Review
  6. Estimating protein isoform abundances with [Formula: see text].Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Article
  8. AnbioRxiv : the preprint server for biology · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

266 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Nicholas T SeyfriedDepartment of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA; Department of Neurology, Emory University School of Medicine, Atlanta, GA 30322, USA. Electronic address: nseyfri@emory.edu.
Eric B DammerDepartment of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.
Vivek SwarupDepartment of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Divya NandakumarDepartment of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.
Duc M DuongDepartment of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.
Luming YinDepartment of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.
Qiudong DengDepartment of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.
Tram NguyenDepartment of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.
Chadwick M HalesDepartment of Neurology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Thomas WingoDepartment of Neurology, Emory University School of Medicine, Atlanta, GA 30322, USA; Division of Neurology, Atlanta VA Medical Center, Decatur, GA 30033, USA.
Jonathan GlassDepartment of Neurology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Marla GearingDepartment of Experimental Pathology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Madhav ThambisettyJohns Hopkins School of Medicine, Baltimore, MD 21205, USA; National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA.
Juan C TroncosoJohns Hopkins School of Medicine, Baltimore, MD 21205, USA.
Daniel H GeschwindDepartment of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
James J LahDepartment of Neurology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Allan I LeveyDepartment of Neurology, Emory University School of Medicine, Atlanta, GA 30322, USA. Electronic address: alevey@emory.edu.
Emory University · USJohns Hopkins Medicine · USUniversity of California, Los Angeles · US

Funding

'T V ASSESSMENT - MEMORY DISORDERED PATIENTS'P50AG005146 · NIA · JOHNS HOPKINS UNIVERSITY · PI HUGANIR, RICHARD L · 1985 to 2019
$37.6M
The Emory Alzheimer's Disease CenterP50AG025688 · NIA · EMORY UNIVERSITY · PI LEVEY, ALLAN I · 2005 to 2019
$25.7M
Understanding mechanisms and seeking novel biomarkers in Alzheimer's diseaseZIAAG000200 · NIA · NATIONAL INSTITUTE ON AGING · PI RESNICK, SUSAN · 2013 to 2024
$12.2M
Discovery of Novel Proteomic Targets in Alzheimer's DiseaseU01AG046161 · NIA · EMORY UNIVERSITY · PI BENNETT, DAVID ALAN, GESCHWIND, DANIEL H · 2014 to 2018
$8.4M
ENNCF - Viral Vector CoreP30NS055077 · NINDS · EMORY UNIVERSITY · PI RESSLER, KERRY J. · 2008 to 2018
$6.8M
Investigating RNA splicing factor aggregations in Alzheimer's disease and CTEK08NS087121 · NINDS · EMORY UNIVERSITY · PI HALES, CHADWICK M · 2014 to 2018
$858k
Predictive Blood and Cerebrospinal Fluid Metabolomic Markers in Alzheimers DiseaseZIAAG000434 · NIA · NATIONAL INSTITUTE ON AGING · PI THAMBISETTY, MADHAV · 2017 to 2017
$701k
A Genetic Study of a Large Pedigree with Late-onset Alzheimer's DiseaseIK2BX001820 · VA · VETERANS HEALTH ADMINISTRATION · PI WINGO, THOMAS SPURGEON · 2014 to 2018
–
BLRD VA IK2 BX001820NIA NIH HHS P50 AG005146NIA NIH HHS P50 AG025688NIA NIH HHS U01 AG046161NINDS NIH HHS K08 NS087121NINDS NIH HHS P30 NS055077
6 · The paper itself

Abstract

Here, we report proteomic analyses of 129 human cortical tissues to define changes associated with the asymptomatic and symptomatic stages of Alzheimer's disease (AD). Network analysis revealed 16 modules of co-expressed proteins, 10 of which correlated with AD phenotypes. A subset of modules overlapped with RNA co-expression networks, including those associated with neurons and astroglial cell types, showing altered expression in AD, even in the asymptomatic stages. Overlap of RNA and protein networks was otherwise modest, with many modules specific to the proteome, including those linked to microtubule function and inflammation. Proteomic modules were validated in an independent cohort, demonstrating some module expression changes unique to AD and several observed in other neurodegenerative diseases. AD genetic risk loci were concentrated in glial-related modules in the proteome and transcriptome, consistent with their causal role in AD. This multi-network analysis reveals protein- and disease-specific pathways involved in the etiology, initiation, and progression of AD.

Indexed as

AgedAged, 80 and overAlzheimer DiseaseAutopsyBrainCognitionCohort StudiesDisease ProgressionFemaleGene Regulatory NetworksGenetic Predisposition to DiseaseHumansMaleNeurogliaNeuronsProtein Processing, Post-TranslationalProteome

Identifiers

PMID27989508
PMCPMC5269514
OpenAlexW2563754444

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.